FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称TUSAMITAMAB RAVTANSINE
异名/同义词IMMUNOGLOBULIN G1, ANTI-(HUMAN CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5) (HUMAN MONOCLONAL SAR408377 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL SAR408377 .KAPPA.-CHAIN, DIMER, AMIDE WITH N2'-(4-((3-CARBOXYPROPYL)DITHIO)-4-METHYL-1-OXOPENTYL)-N2'-DEACETYLMAYTANSINE
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CARCINOEMBRYONIC ANTIGEN, MECONIUM ANTIGEN 100, ANTIGEN_CD66E)) HUMANIZED MOUSE MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN (1-449) (VH(MUS MUSCULUS IGHV5-12-1*01 (87%)-(IGHD)-IGHJ3*01 (93%)/HOMO SAPIENS IGHV3-23*01 (77%) IGHJ4*01 (93%)) (8.8.13) (1-120)-HOMO SAPIENS IGHG1*01 (CH3(K107>DEL(450))) (121-449) (223-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (V-KAPPA (MUS MUSCULUS IGKV12-44*01 (87%)-IGKJ4*01/HOMO SAPIENS IGKV1-39*01 (82%)-IGKJ2*02 (91%))(6.3.9) (1'-107') HOMO SAPIENS IGKC*01 (108'-214')), DIMER (229-229'':232-232'')-BISDISULFIDE, PRODUCED IN CHO CELL, GLYCOFORM ALFA; 3 OR 4 (N) LYSINES ARE N6 SUBSTITUTED BY RAVTANSINE
MAYTANSIN-LOADED ANTI-CEACAM5 MAB
SAR408701
SAR-408701
TUSAMITAMAB RAVTANSINE
TUSAMITAMAB RAVTANSINE [INN]
TUSAMITAMAB RAVTANSINE [USAN]
TUSAMITAMAB RAVTANSINE [WHO-DD]
CAS登记号2254086-60-5
物质唯一标识(Unique Ingredient Identifier)DSS3BE2ZXN
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System